GlassScriptPhysician profile
Syed Kamran
NPI 1144842113
$3,159.27
in general payments reported to CMS, 2019-2025
36 companies · $1,111 in 2025
The $1,111 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $225 · 2023: $526 · 2024: $1,173 · 2025: $1,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,639 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,638.71 |
| Education | $170.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $511.87 | 2023-2025 | Jakafi, Monjuvi, Niktimvo |
| Rigel Pharmaceuticals, INC. | $169.77 | 2023-2024 | Rezlidhia, Tavalisse |
| Caris Mpi, INC. | $160.50 | 2025 | Mi Cancer Seek |
| Genmab U.S., INC. | $137.77 | 2023-2025 | Epkinly |
| Merck Sharp & Dohme LLC | $137.68 | 2024-2025 | Keytruda, Welireg, Reblozyl |
| E.R. Squibb & Sons, L.L.C. | $132.87 | 2024 | |
| Beigene USA, INC. | $125.00 | 2022 | |
| Epizyme, INC. | $124.97 | 2021 | |
| Penumbra, INC. | $119.63 | 2025 | Indigo System |
| Sobi, INC | $113.12 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $109.41 | 2023-2025 | Libtayo |
| Karyopharm Therapeutics INC. | $108.00 | 2023-2025 | Xpovio |
| Pfizer INC. | $99.65 | 2022 | |
| Morphosys, US INC. | $90.92 | 2023 | Monjuvi |
| Adc Therapeutics America, INC. | $89.38 | 2023-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $77.28 | 2023-2024 | Ayvakit |
| Adaptive Biotechnologies Corporation | $76.83 | 2023-2024 | Clonoseq |
| Geron Corporation | $73.66 | 2025 | Rytelo |
| Exelixis INC. | $69.82 | 2025 | Cabometyx |
| Servier Pharmaceuticals LLC | $68.18 | 2024 | |
| Syndax Pharmaceuticals, INC. | $66.08 | 2025 | |
| Janssen Biotech, INC. | $66.03 | 2024-2025 | Carvykti, Tecvayli, Darzalex |
| Genzyme Corporation | $64.43 | 2024 | |
| Kite Pharma, INC. | $55.12 | 2024-2025 | Yescarta |
| Astellas Pharma US INC | $34.16 | 2025 | Xtandi |
| Deciphera Pharmaceuticals INC. | $29.86 | 2023 | Qinlock |
| Takeda Pharmaceuticals U.S.A., INC. | $29.57 | 2023 | Ninlaro |
| Jazz Pharmaceuticals INC. | $29.43 | 2024 | |
| Springworks Therapeutics, INC. | $29.28 | 2025 | Ogsiveo |
| Novocure INC. | $26.53 | 2025 | Optune Gio |
| Bayer Healthcare Pharmaceuticals INC. | $24.97 | 2024 | |
| Lilly USA, LLC | $22.38 | 2024 | Jaypirca |
| Neurelis, INC. | $22.24 | 2025 | Valtoco |
| Glaxosmithkline, LLC. | $22.00 | 2025 | Ojjaara |
| Seagen INC. | $21.47 | 2023 | Adcetris |
| Mirati Therapeutics, INC. | $19.41 | 2023 | Krazati |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Kamran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.